Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain

Pain

Volumn 84, Issue 2-3, 2000, Pages 397-405

  Talhouk, R S ^a   Hajjar, L ^a   Abou Gergi, R ^a   Simaa'n, C J ^a   Mouneimne, G ^a   Saade', N E ^b   Safieh Garabedian, B ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b

^c Lebanon

Author keywords

ECM degrading proteinases; Endotoxin; Gelatinases; Hyperalgesia

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; GELATINASE; ILOMASTAT; METALLOPROTEINASE INHIBITOR; MORPHINE; NALOXONE; PROTEINASE; THYMULIN; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HOT PLATE TEST; HYPERALGESIA; INFLAMMATION; LIMB; MALE; MOUSE; NONHUMAN; PAIN; PAW PRESSURE TEST; PRESSURE; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; ENDOTOXINS; ENZYME INHIBITORS; GELATINASES; HEAT; HINDLIMB; HYPERALGESIA; INFLAMMATION; MALE; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; PAIN; PHYSICAL STIMULATION; SODIUM CHLORIDE; THYMIC FACTOR, CIRCULATING; ZINC;

EID: 0033979429     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00238-9     Document Type: Article

References (42)

1. Andreev N.Y., Dimitrieva N., Koltzenburg M., McMahon S.B. Peripheral administration of nerve growth factor in the adult rat produces thermal hyperalgesia that requires the presence of sympathetic postganglionic neurones. Pain. 63:1995;109-115.
2. Corcoran M.L., Stelter-Stevenson W.G., Brown P.D., Wahl L.M. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92 kD type IV collagenase/gelatinase production by human monocytes. J Biol Chem. 267:1992;515-519.
3. D'Ortho M.P., Jarreau P.H., Delacourt C., Macquin-Mavier I., Levame M., Pezet S., Harf A., Lafuma C. Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol. 266:1994;L209-L216.
4. Dayer J.M., Burger D. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Network. 5:(6):1994;563-571.
5. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 334:1988;698-700.
6. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of IL-1 in the rat. Brain Res. 657:1994;133-140.
7. Gearing A.J.H., Bekett P., Christodoulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangen M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., Wooley K. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature. 370:1994;555-557.
8. Gearing A.J.H., Beckett P., Christodoulou M., Churchill M., Clements J.M., Crimmin M., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., Wooley K. Matrix metalloproteinases and processing of pro-TNF-α J Leukocyte Biol. 57:1995;774-777.
9. Gijbels K., Galardy R.E., Steiman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of metalloproteinases. J Clin Invest. 94:(6):1994;2177-2182.
10. Gottschall P.E., Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 64:1995;1513-1520.
11. Israel H.A., Ramamurthy N.S., Greenwald R., Golub L. The potential role of doxycycline in the treatment of osteoarthritis of the temporomandibular joint. Adv Dent Res. 12:1998;51-55.
12. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I., Enghild J., Sasaguri Y., Mori Y. Degradation of interleukin-1β by matrix metalloproteinases. J Biol Chem. 271:(5):1996;1465-1466.
13. Kanaan S.A., Saade N.E., Haddad J.J., Abdelnour A.M., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Endotoxin-induced local inflammation and hyper-algesia in rats and mice: a new model for inflammatory pain. Pain. 66:1996;373-379.
14. Kanaan S.A., Saade N.E., Haddad J.J., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Effects of various analgesic and anti-inflammatory drugs on endotoxin-induced hyperalgesia in rats and mice. Pharmacology. 54:1997;285-297.
15. Kanaan S.A., Poole S., Saade N.E., Jabbur S.J., Safieh-Garabedian B. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J Neuroimmunol. 86:1998;142-150.
16. Levine J.D., Dardick S.J., Basbaum A.I., Scipio E. Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci. 5:1985;1380-1386.
17. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 13:1993;2136-2148.
18. McGeehan G.M., Becherer J.D., Bast R.C. Jr, Boyer C.M., Champion B., Conolly K.M., Conway J.G., Furdon P., Karp S., Kidao S., McElroy A.B., Nicholas J., Pryzwansky K.M., Schoenen F., Sekut L., Truesdale A., Verghese M., Warner J., Ways J.P. Regulation of tumor necrosis factor α processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
19. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K., Kronheim S.R., Petersen M., Gerhart M., Kozlosky C.J., March C.J., Black R.A. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature. 370:1994;218-220.
20. Murakami K., Kobayashi F., Ikegawa R., Koyama M., Shintani N., Yoshida T., Nakamura N., Kondo T. Metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice. Eur J Pharmacol. 341:1998;105-110.
21. Nordstrom D., Lindy O., Lauhio A., Sorsa T., Santavirta S., Konttinen Y.T. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int. 17:1998;175-180.
22. Okada A., Tomasetto C., Lutz Y., Bellocq J.P., Rio M.C., Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 MMP is a stromal activator of pro-gelatinase A. J Cell Biol. 137:(1):1997;67-77.
23. Prontera C., Crescenzi G., Rotilio D. Inhibition by IL-4 of stromelysin expression in human skin fibroblasts: role of PKC. Exp Cell Res. 224:1996;183-188.
24. Saade' N.E., Abou-Jaoude P.G., Saadeh F.A., Hamouie S., Safieh-Garabedian S.A., Kanaan B., Atweh S.F., Jabbur S.J. Fos-like immunoreactivity induced by intra-plantar injection of endotoxin and its reduction by morphine. Brain Res. 769:1997;57-65.
25. Saade' N.E., Kanaan S.A., Haddad J.J., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Dissociation between peripheral and central components of the endotoxin-induced hyperalgesia. Ayrapetyan, Apkarian. Pain mechanisms and management. 1998;120-130.
26. Saarialho-Kere U.K., Pentland A.P., Birkedal-Hansen H., Parks W.C., Howard H.G. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest. 94:1994;79-88.
27. Safieh-Garabedian B., Jalakhian R.H., Saade N.E., Haddad J.J., Jabbur S.J., Kanaan S.A. Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res. 717:1996;179-183.
28. Safieh-Garabedian B.S., Poole S., Allchorne A., Kanaan S., Saade N., Woolf C. Zinc reduces the hyperalgesia and upregulation of NGF and IL-1β produced by peripheral inflammation in the rat. Neuropharmacology. 35:1996;599-603.
29. Safieh-Garabedian B., Kanaan S.A., Haddad J.J., Abou Jaoude P., Jabbur S.J., Saade N.E. Involvement of interleukin-1β, nerve growth factor and prostaglandin-E2 in endotoxin induced localized inflammatory hyperalgesia. Br J Pharmacol. 121:1997;1619-1626.
30. Safieh-Garabedian B., Kanaan S.A., Jalakhian R.H., Poole S., Jabbur S.J., Saade N.E. Hyperalgesia induced by low doses of thymulin injections: possible involvement of prostaglandin-E2. J Neuroimmunol. 73:1997;162-168.
31. Safieh-Garabedian B., Jalakhian R.H., Jabbur S.J., Saade' N.E., Kanaan S.A. Thymulin at high doses reduces endotoxin-induced hyperalgesia by reducing interleukin-1β and nerve growth factor levels in the hind paw of rats. Ayrapetyan S.N., Apkarian A.V. Pain mechanisms and management. 1998;131-138.
32. Salo T., Makela M., Kylmaniemi M., Autio-Harmainen H., Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest. 70:(2):1994;176-182.
33. Solorzano C.C., Ksontini R., Pruitt J.H., et al. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor-α (TNF-α) and abrogates endotoxin-induced lethality. Shock. 7:1997;427-431.
34. Sommer C., Schmidt C., George A., Tokya K.V. A metalloproteinase-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett. 237:1997;45-48.
35. Stricklin G.P., Li L., Jancic V., Wenczak B.A., Nanney L.B. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol. 143:(6):1993;1657-1666.
36. Talhouk R.S., Chin J.R., Unemori E.N., Werb Z., Bissell M.J. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development. 112:1991;439-449.
37. Talhouk RS, Hajjar L, Abou-Gergi R, Saade NE, Safieh-Garabedian B. Modulation of hyperalgesia and ECM-degrading proteinases in an endotoxin mediated local and reversible acute inflammation. 27th Annual Meeting of the Society for Neuroscience 704.6 (abstract). 1997.
38. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
39. White D.M. Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons. Neuroscience. 70:1996;561-565.
40. Woessner J.F. Jr. Matrix metalloproteinase and their inhibitors in connective tissue remodelling. Fed Am Soc Exp Biol J. 5:1991;2145-2154.
41. Woolf C.J., Safieh-Garabedian B., Ma Q.P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.
42. Wysocki A.B., Stain-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 101:1993;64-68.